Clinical Trial Update: A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7497372 in Participants With Diabetic Macular Edema (DME) [Phase 1]

View source ↗

Summary

Phase 1 study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of RO7497372 in participants with diabetic macular edema. The study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• RO7497372

Snippet

Sponsor: Genentech, Inc. | Conditions: Diabetic Macular Edema | Phase 1 | Status: ACTIVE_NOT_RECRUITING